BioSapien extends its pre-Series A round to $7 million - Wamda

Retrieved on: 2025-01-27 10:25:36

Tags for this article:

Arabian Peninsula

United Arab Emirates

Abu Dhabi

Clinical trial

BioSapien

Click the tags to see associated articles and topics

BioSapien extends its pre-Series A round to $7 million - Wamda. View article details on hiswai:

Summary

BioSapien, a biotech firm in Abu Dhabi, is advancing clinical trials for its 3D-printed drug delivery platform, MediChip™, emphasizing the UAE's role in healthcare innovation. The $7 million funding aligns with UAE's biomedical advancement goals.

Article found on: www.wamda.com

View Original Article